Pilulka Lekarny AS (XPRA:PINK) Cash-to-Debt : 0.14 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Pilulka Lekarny AS Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Pilulka Lekarny AS's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.14.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Pilulka Lekarny AS couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Pilulka Lekarny AS's Cash-to-Debt or its related term are showing as below:

XPRA:PINK' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.14 Med: No Debt Max: No Debt
Current: 0.14

During the past 6 years, Pilulka Lekarny AS's highest Cash to Debt Ratio was No Debt. The lowest was 0.14. And the median was No Debt.

XPRA:PINK's Cash-to-Debt is ranked worse than
75.6% of 668 companies
in the Healthcare Providers & Services industry
Industry Median: 0.69 vs XPRA:PINK: 0.14

Pilulka Lekarny AS Cash-to-Debt Historical Data

The historical data trend for Pilulka Lekarny AS's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Pilulka Lekarny AS Cash-to-Debt Chart

Pilulka Lekarny AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

No Debt

0.24

0.14

Pilulka Lekarny AS Semi-Annual Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Cash-to-Debt	Get a 7-Day Free Trial			No Debt	No Debt	No Debt	0.24	0.14

Competitive Comparison of Pilulka Lekarny AS's Cash-to-Debt

For the Pharmaceutical Retailers subindustry, Pilulka Lekarny AS's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pilulka Lekarny AS's Cash-to-Debt Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pilulka Lekarny AS's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Pilulka Lekarny AS's Cash-to-Debt falls into.

Pilulka Lekarny AS Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Pilulka Lekarny AS's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	10.847	/	(73.328	+	3.675)
	=	0.14

Pilulka Lekarny AS's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	10.847	/	(73.328	+	3.675)
	=	0.14

Pilulka Lekarny AS (XPRA:PINK) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Pilulka Lekarny AS Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Pilulka Lekarny AS's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Pilulka Lekarny AS (XPRA:PINK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pilulka Lekarny AS (XPRA:PINK) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Drahobejlova 1073/36, Prague, CZE, 190 00

Website

https://www.pilulka.cz

Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.

Pilulka Lekarny AS (XPRA:PINK) Headlines

From GuruFocus

LEE DANNER & BASS INC Buys 3, Sells 2 in 3rd Quarter

By GuruFocus Research GuruFocus Editor • 10-31-2022

Top 5 4th Quarter Trades of LEE DANNER & BASS INC

By GuruFocus Research GuruFocus Editor • 02-02-2023